ea0037ep575 | Obesity and cardiovascular endocrinology | ECE2015
Mat Arimin
, Ahern Tomas
, Breen Cathy
, Dunlevy Colin
, O'Shea Donal
Background: Many antipsychotics are obesogenic and contribute to significant weight gain with serious implications on patientsÂ’ physical and mental well-being. However, patients on antipsychotics are often excluded from unmodified lifestyle-intervention weight management programmes and trials.Objectives: To determine if weight loss is possible for antipsychotic-medicated obese patients when enrolled in an unmodified lifestyle-intervention weight man...